Bernard Coulie, President and CEO at PLIANT THERAPEUTICS, INC. (PLRX), sold 3,500 shares at $30.33 ($106K) on 2021-04-14, disclosed to the SEC on 2021-04-15.
Open-market sale of $106k PLRX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PLRX | SELL | 2024-07-12 | $895K | — | Filing → |
| PLRX | SELL | 2024-01-19 | $886K | — | Filing → |
| PLRX | SELL | 2023-07-19 | $2.5M | — | Filing → |